TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7992933

Group type: EXPERIMENTAL
Intervention: Amoxicillin (1 g intravenous injection immediately after induction of anaesthesia, followed by postoperative injections every 6 hours for 36 hours, total of 6 injections)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Cefamandole (1.5 g intravenous injection immediately after induction of anaesthesia, followed by postoperative injections every 6 hours for 36 hours, total of 6 injections)
Number of subjects: 256
Study: 2736886

Group type: EXPERIMENTAL
Intervention: Breath-holding for 6 seconds
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Breath-holding for 10 seconds
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Qc in patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Qc in normal subjects
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Qf
Number of subjects: 39
Study: 29206596

Group type: EXPERIMENTAL
Intervention: Computer-Aided Detection (CAD) system
Number of subjects: 100

Group type: COMPARATOR
Intervention: No Computer-Aided Detection (CAD) system
Number of subjects: 100
Study: 26707087

Group type: EXPERIMENTAL
Intervention: .20 mg/kg esketamine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: .40 mg/kg esketamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 24883300

Group type: EXPERIMENTAL
Intervention: 0.30 mg/kg rectal midazolam diluted with 5 mL saline (Group M)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5 mL saline (Group C)
Number of subjects: 40
Study: 22467361

Group type: EXPERIMENTAL
Intervention: Resource-oriented cognitive-behavioral therapy (ROCBT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: ROCBT and CT
Number of subjects: 51
Study: 20554904

Group type: EXPERIMENTAL
Intervention: Oral sea buckthorn (SB) oil, 2 g daily for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo oil, 2 g daily for 3 months
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral sea buckthorn (SB) oil
Number of subjects: 100
Study: 18414195

Group type: EXPERIMENTAL
Intervention: Written invitation letter
Number of subjects: 43523

Group type: COMPARATOR
Intervention: Control group (no invitation letter)
Number of subjects: 43523
Study: 15750155

Group type: EXPERIMENTAL
Intervention: Biphasic injection (90 and 50 mL at 3 and 1.5 mL/s) of intravenous contrast (300 mg/mL iodine)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Triple-phase injection (90, 40, and 40 mL at 3, 2, and 1.5 mL/s)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dual-phase injection (80 and 60 mL at 3 and 1.5 mL/s) in the caudocranial direction with a 50-s delay
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intravenous contrast agent
Number of subjects: 40
Study: 11919643

Group type: EXPERIMENTAL
Intervention: Summer's Eve (SE) vaginal moisturizer based on pectin
Number of subjects: 51

Group type: COMPARATOR
Intervention: Replens (Rp) vaginal moisturizer based on polycarbophil
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Summer's Eve (SE) vaginal moisturizer
Number of subjects: 51

Group type: COMPARATOR
Intervention: Replens (Rp) vaginal moisturizer
Number of subjects: 51
Study: 10989865

Group type: EXPERIMENTAL
Intervention: Ketamine 5 mg iv
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl 50 microg iv
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline 2 ml iv
Number of subjects: 60
Study: 8822682

Group type: EXPERIMENTAL
Intervention: Intramuscular gentamicin
Number of subjects: 142

Group type: COMPARATOR
Intervention: Oral antibiotics
Number of subjects: 142
Study: 1424430

Group type: EXPERIMENTAL
Intervention: d-methylphenidate
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: l-methylphenidate
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: dl-methylphenidate
Number of subjects: 9

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study: 3906218

Group type: EXPERIMENTAL
Intervention: RFP plus INH for 9 months (R9 group)
Number of subjects: 151

Group type: COMPARATOR
Intervention: RFP plus INH for 12 months (R12 group)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: R9 group
Number of subjects: 151

Group type: COMPARATOR
Intervention: R12 group
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 151

Group type: COMPARATOR
Intervention: Complicated case with diabetes mellitus in R12 group
Number of subjects: 151
Study: 31096485

Group type: EXPERIMENTAL
Intervention: Template matching
Number of subjects: 240

Group type: COMPARATOR
Intervention: Regression model
Number of subjects: 240
Study: 29683690

Group type: EXPERIMENTAL
Intervention: Scarcity and authority manipulation in Experiment 1
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Low, medium, or high activation fee in Experiment 2
Number of subjects: 502
Study: 26228264

Group type: EXPERIMENTAL
Intervention: Walking intervention (n=11)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study: 23384155

Group type: EXPERIMENTAL
Intervention: Narrative version of the video decision aid (includes stories from breast cancer survivors)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control version of the video decision aid (no patient stories)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Narrative version of the video decision aid
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control version of the video decision aid
Number of subjects: 200
Study: 22726401

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: Beta-blocker titration
Number of subjects: 876
Study: 20087086

Group type: EXPERIMENTAL
Intervention: TZP-101 (80 microg/kg)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: TZP-101 (480 microg/kg)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: TZP-101
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 16856128

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 83
Study: 15703894

Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 597

Group type: COMPARATOR
Intervention: Isocaloric control formula
Number of subjects: 597
Study: 11696811

Group type: EXPERIMENTAL
Intervention: Alarm therapy combined with 40 microg intranasal desmopressin for 3 weeks followed by 20 microg desmopressin for 3 weeks (group 1)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Alarm therapy and placebo (group 2)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both treatment modalities (group 1 and group 2)
Number of subjects: 93
Study: 9216706

Group type: EXPERIMENTAL
Intervention: Systemic therapy plus radiotherapy (Arm B)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Systemic therapy alone (Arm A)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: T-status at diagnosis
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Disease-free interval from diagnosis to recurrence
Number of subjects: 37
Study: 7970071

Group type: EXPERIMENTAL
Intervention: Chemiluminescence molecular hybridization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional examinations (colposcopy, cytology, histology)
Number of subjects: 0
Study: 3301454

Group type: EXPERIMENTAL
Intervention: Dothiepin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2213264

Group type: EXPERIMENTAL
Intervention: Tocolysis and prophylactic antibiotic administration
Number of subjects: 112

Group type: COMPARATOR
Intervention: Passive expectant management (control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Ceftizoxime
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Other antibiotics (cefoxitin, cefazolin, ampicillin)
Number of subjects: 112
Study: 4320676

Group type: EXPERIMENTAL
Intervention: Kiil dialyser
Number of subjects: 24

Group type: COMPARATOR
Intervention: Coil dialyser
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Home dialysis with Kiil dialyser
Number of subjects: 24

Group type: COMPARATOR
Intervention: Home dialysis with coil dialyser
Number of subjects: 24
Study: 30149148

Group type: EXPERIMENTAL
Intervention: G‐CSF + plerixafor
Number of subjects: 20

Group type: COMPARATOR
Intervention: G‐CSF alone
Number of subjects: 20
Study: 28777665

Group type: EXPERIMENTAL
Intervention: Double-row repair with sutures
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Double-row repair with labral tape
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-row repair with simple sutures
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-row repair with horizontal mattress sutures
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-row vs Double-row techniques
Number of subjects: 24

Group type: COMPARATOR
Intervention: Simple suture vs Horizontal mattress suture
Number of subjects: 24

Group type: COMPARATOR
Intervention: Double-row techniques with sutures vs labral tape
Number of subjects: 24
Study: 26324857

Group type: EXPERIMENTAL
Intervention: High (therapeutic) stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low (subtherapeutic) stimulation
Number of subjects: 12
Study: 23230898

Group type: EXPERIMENTAL
Intervention: NODAT within 1 year
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Recipient age (per year)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Age (at 3 months)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (at 3 months)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All-cause mortality in NODAT recipients
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Age (HR 1.075, CI 1.042-1.110)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 1-year creatinine (HR 1.007, CI 1.004-1.010)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: NODAT within 3 months (HR 2.4, CI 1.2-4.9)
Number of subjects: 118
Study: 21641196

Group type: EXPERIMENTAL
Intervention: Flutter(®)VRP1
Number of subjects: 18

Group type: COMPARATOR
Intervention: PEP
Number of subjects: 18
Study: 19262975

Group type: EXPERIMENTAL
Intervention: Exercise group (EG) - supervised high-impact exercises three times per week for 12 months.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (CG) - no exercise intervention.
Number of subjects: 120
Study: 16442893

Group type: EXPERIMENTAL
Intervention: Patients with cardiac tamponade
Number of subjects: 102060

Group type: COMPARATOR
Intervention: Patients without cardiac tamponade
Number of subjects: 102060
Study: 15017898

Group type: EXPERIMENTAL
Intervention: Concomitant chemo‐radiotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 80
Study: 11343668

Group type: EXPERIMENTAL
Intervention: Risk factor case-management program (n = 99)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Care as usual (n = 102)
Number of subjects: 201
Study: 9216955

Group type: EXPERIMENTAL
Intervention: Melatonin (Mel) 5 mg po administered at 1300
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Postural change from upright to supine position at 1000
Number of subjects: 8
Study: 7970472

Group type: EXPERIMENTAL
Intervention: Intrapartum intrathecal narcotic analgesia (25 micrograms fentanyl and 0.25 mg morphine sulfate)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intrapartum intrathecal narcotic analgesia
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (matched by gravidity and parity)
Number of subjects: 150
Study: 3313684

Group type: EXPERIMENTAL
Intervention: Relaxation therapy for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation therapy
Number of subjects: 0
Study: 29189540

Group type: EXPERIMENTAL
Intervention: Subtenon irrigation of Mitomycin-C
Number of subjects: 100

Group type: COMPARATOR
Intervention: Subtenon sponge application of Mitomycin-C
Number of subjects: 100

Group type: COMPARATOR
Intervention: Trabeculectomy/Ex-PRESS alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 100
Study: 28923050

Group type: EXPERIMENTAL
Intervention: Dry needling (DN), manual physiotherapy and therapeutic exercise
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham dry needling, manual physiotherapy and therapeutic exercise
Number of subjects: 36
Study: 26352805

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT 5716 at 3×10(9) CFU/day
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT 5716 at 6×10(9) CFU/day
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT 5716 at 9×10(9) CFU/day
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 4
Study: 23442315

Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 60

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 60
Study: 25426790

Group type: EXPERIMENTAL
Intervention: Edible yogurt containing Lactobacillus rhamnosus L8020
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo yogurt
Number of subjects: 50
Study: 19832996

Group type: EXPERIMENTAL
Intervention: Collaborative care (case manager coordinated support and brief psychological treatment, enhanced specialist and GP communication)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 16467233

Group type: EXPERIMENTAL
Intervention: Low-fat dietary modification intervention (n = 19,541)
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Comparison group (usual eating pattern, n = 29,294)
Number of subjects: 48835

Group type: EXPERIMENTAL
Intervention: Low-fat dietary modification intervention
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 48835
Study: 15475128

Group type: EXPERIMENTAL
Intervention: Flat tibial insert with retention of the posterior cruciate ligament
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Concave tibial insert with retention of the posterior cruciate ligament
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Concave tibial component with resection of the posterior cruciate ligament
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Posterior-stabilized tibial component with resection of the posterior cruciate ligament
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 11318768

Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg daily if creatinine < 150 micromol l‐1 or 100 mg if creatinine > 150 micromol l‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10481379

Group type: COMPARATOR
Intervention: Hyperthyroidism
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pharmacological euthyroidism
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Euthyroidism after surgical treatment
Number of subjects: 10
Study: 7962578

Group type: EXPERIMENTAL
Intervention: Eye movement desensitization (EMD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Finger tapping (control)
Number of subjects: 30
Study: 3307897

Group type: EXPERIMENTAL
Intervention: Humphrey automated threshold perimetry (Program 30‐2)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Goldmann perimetry
Number of subjects: 25

Group type: COMPARATOR
Intervention: Humphrey automated perimetry
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Humphrey automated perimetry (Program 30‐2)
Number of subjects: 25
Study: 31272205

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (endurance and resistance training with moderate intensity, at least three times per week for six months)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 61
Study: 27882653

Group type: EXPERIMENTAL
Intervention: Sunnybrook composite score at 1 month
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Symmetry of voluntary movement at 1 month
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Gentle eye closure and open-mouth smile
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Synkinesis frequency
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Moderate to severe synkinesis
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Mean synkinesis score
Number of subjects: 743
Study: 25185932

Group type: COMPARATOR
Intervention: Calcium alginate
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Hydrofiber
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Foam
Number of subjects: 57
Study: 23741380

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 21091548

Group type: COMPARATOR
Intervention: N-Bt diet
Number of subjects: 33

Group type: COMPARATOR
Intervention: Bt diet
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control and N-Bt diet
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 33
Study: 18815144

Group type: EXPERIMENTAL
Intervention: Plant-based diet and stress reduction
Number of subjects: 0
Study: 16428337

Group type: EXPERIMENTAL
Intervention: LCA group (n = 36)
Number of subjects: 50

Group type: COMPARATOR
Intervention: RCA group (n = 14)
Number of subjects: 50
Study: 12636888

Group type: COMPARATOR
Intervention: 20 degrees C condition
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 35 degrees C condition
Number of subjects: 34
Study: 10618562

Group type: EXPERIMENTAL
Intervention: Immediate suture closure with the double-suture Prostar-Plus device
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed sheath removal with application of a c-clamp
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 8738356

Group type: EXPERIMENTAL
Intervention: Composite vibration composed of two 1/3 octave‐band vibrations
Number of subjects: 8

Group type: COMPARATOR
Intervention: 1/3 octave‐band vibrations (63, 200, and 500 Hz)
Number of subjects: 8
Study: 1574461

Group type: EXPERIMENTAL
Intervention: DRE with TRUS
Number of subjects: 0

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DRE with TRUS and PSA measurement if results are suspicious
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-screen PSA
Number of subjects: 0
Study: 6373102

Group type: EXPERIMENTAL
Intervention: Prochlorperazine (6 mg/sq m)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Haloperidol (1 mg/sq m)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Droperidol (1 mg/sq m)
Number of subjects: 27
Study: 31834923

Group type: EXPERIMENTAL
Intervention: Telephone administration of the Patient-Specific Functional Scale (PSFS)
Number of subjects: 74

Group type: COMPARATOR
Intervention: In-person administration of the Patient-Specific Functional Scale (PSFS)
Number of subjects: 74
Study: 29743962

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fentanyl (50 mg)
Number of subjects: 80
Study: 25884637

Group type: EXPERIMENTAL
Intervention: Home-based 12-week physical activity intervention program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 30
Study: 24002802

Group type: EXPERIMENTAL
Intervention: Poor functional vision group (n=95)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Functional vision
Number of subjects: 576
Study: 21310741

Group type: EXPERIMENTAL
Intervention: Second-generation high-flux dialyser (Polynephron)
Number of subjects: 14

Group type: COMPARATOR
Intervention: First-generation high-flux dialyser (DIAPES-HF800)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Convection dialysis strategy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Diffusion dialysis strategy
Number of subjects: 14
Study: 19750873

Group type: EXPERIMENTAL
Intervention: Prismatic displacement adaptation with a concurrent cognitive task (serial subtractions of 7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prismatic displacement adaptation with a concurrent cognitive task (repeating back tones)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prismatic displacement adaptation without a concurrent cognitive task
Number of subjects: 0
Study: 17578562

Group type: EXPERIMENTAL
Intervention: 17OHPC (250 mg intramuscular injections weekly from 16-20 weeks up to 36 weeks)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: 17OHPC
Number of subjects: 660
Study: 15565072

Group type: EXPERIMENTAL
Intervention: Glucose drink
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: White bagel
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Peanuts
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Protein bar
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Protein drink
Number of subjects: 12
Study: 11563245

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9822209

Group type: EXPERIMENTAL
Intervention: smiling scale/sensory instructions
Number of subjects: 100

Group type: COMPARATOR
Intervention: neutral scale/sensory instructions
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: smiling scale/affective instructions
Number of subjects: 100
Study: 9400343

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1850282

Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Lactated Ringer's (LR)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Normal Saline adjusted to pH 7.4 with sodium bicarbonate (NS + Bicarb)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Balanced Saline Solution Plus (BSS Plus)
Number of subjects: 4
Study: 7067541

Group type: EXPERIMENTAL
Intervention: Epidural opiates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic analgesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with local anesthetics (EPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative peridural opiates
Number of subjects: 0
Study: 30098860

Group type: EXPERIMENTAL
Intervention: Bioimpedance (BCM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: DEXA
Number of subjects: 120